Retour
UCB SA (UCBJY) Gagner
Graphique du cours de l'action UCBJY
UCBJY Gagner
UCB SA
$146.73
1.46%
$2.11
À la fermeture : Mar 25, 16:00:00 GMT-4
$146.73
0%
$0
Post-Marché: Mar 25, 20:00:00 GMT-4
Statistiques clés
Clôture préc.
$144.61
Prix d'ouverture
$145.74
Plage de la journée
$145.12 - $147.99
Plage de 52 semaines
$71.15 - $168.76
Volume
5.4K
Volume moyen
30.1K
Rendement en dividend
--
BPA (TTM)
4.03
Capitalisation boursière
$55.7B
Qu’est-ce que UCB S.A. ?
UCB SA engages in the research and development of biopharmaceuticals products. The company is headquartered in Anderlecht, Bruxelles-Capitale. In the area of central nervous system disorders, the Company is focused on epilepsy, diabetic neuropathic pain, multiple sclerosis, fibromyalgia, restless legs syndrome and Parkinson’s disease, and the area of immunology includes, bone loss disorders, Crohn’s disease, rheumatoid arthritis and respiratory disease. In addition to its core fields of business, Ucb SA delivers molecule solutions to specialists for use in the treatment of severe diseases. Its product portfolio includes drugs, such as Neupro, Vimpat, Cimzia, among others. Ucb SA also operates in primary care to support specialist products that are administered by primary care physicians.
Fonctionnalités
Ressources
© 2026 Finture Development Limited. Tous droits réservés.